Literature DB >> 668784

Absorption of oral and intramuscular chlordiazepoxide.

D J Greenblatt, R I Shader, S M MacLeod, E M Sellers, K Franke, H G Giles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 668784     DOI： 10.1007/BF00716362

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  14 in total

1.  Intramuscular injection of drugs.

Authors:  D J Greenblatt; J Koch-Weser
Journal:  N Engl J Med       Date:  1976-09-02       Impact factor: 91.245

2.  Absorption and disposition of chlordiazepoxide in young and elderly male volunteers.

Authors:  R I Shader; D J Greenblatt; J S Harmatz; K Franke; J Koch-Weser
Journal:  J Clin Pharmacol       Date:  1977 Nov-Dec       Impact factor: 3.126

3.  Serum creatine phosphokinase concentrations after intramuscular chlordiazepoxide and its solvent.

Authors:  D J Greenblatt; R I Shader; J Koch-Weser
Journal:  J Clin Pharmacol       Date:  1976 Feb-Mar       Impact factor: 3.126

4.  Effect of oral and intramuscular routes of administration on serum chlordiazepoxide levels and the prediction of these levels from predrug fasting serum glucose concentrations.

Authors:  L A Gottschalk; R Biener; E C Dinovo
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1974-08

5.  Statistical estimations in pharmacokinetics.

Authors:  H G Boxenbaum; S Riegelman; R M Elashoff
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

6.  Slow absorption of intramuscular chlordiazepoxide.

Authors:  D J Greenblatt; R I Shader; J Koch-Weser
Journal:  N Engl J Med       Date:  1974-11-21       Impact factor: 91.245

7.  Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration.

Authors:  D J Greenblatt; H J Pfeifer; H R Ochs; K Franke; D S MacLaughlin; T W Smith; J Koch-Weser
Journal:  J Pharmacol Exp Ther       Date:  1977-08       Impact factor: 4.030

8.  Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: single-dose studies by the intravenous, intramuscular, and oral routes.

Authors:  H G Boxenbaum; K A Geitner; M L Jack; W R Dixon; H E Spiegel; J Symington; R Christian; J D Moore; L Weissman; S A Kaplan
Journal:  J Pharmacokinet Biopharm       Date:  1977-02

9.  Control of acute alcoholic withdrawal symptoms: a comparative study of haloperidol and chlordiazepoxide.

Authors:  M L Palestine; E Alatorre
Journal:  Curr Ther Res Clin Exp       Date:  1976-09

10.  Influence of magnesium and aluminum hydroxide mixture on chlordiazepoxide absorption.

Authors:  D J Greenblatt; R I Shader; J S Harmatz; K Franke; J Koch-Weser
Journal:  Clin Pharmacol Ther       Date:  1976-02       Impact factor: 6.875
View more
  9 in total

Review 1.  Clinical issues related to the costs of alcoholism.

Authors:  M O Howard; R W McGuffin; A J Saxon; K L Sloan; R D Walker
Journal:  Pharmacoeconomics       Date:  1996-02       Impact factor: 4.981

2.  Single and multiple dose kinetics of clobazam, and clinical effects during multiple dosage.

Authors:  H R Ochs; D J Greenblatt; M Lüttkenhorst; B Verburg-Ochs
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 3.  The use of benzodiazepines in clinical practice.

Authors:  R I Shader; D J Greenblatt
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

Review 4.  The pharmacological role of the kidney.

Authors:  D C Brater
Journal:  Drugs       Date:  1980-01       Impact factor: 9.546

5.  A multicenter study of ICU drug utilization.

Authors:  M L Farina; A Levati; G Tognoni
Journal:  Intensive Care Med       Date:  1981-04       Impact factor: 17.440

6.  Clinical pharmacokinetics of chlordiazepoxide in patients with alcoholic hepatitis.

Authors:  D D Morgan; J D Robinson; C L Mendenhall
Journal:  Eur J Clin Pharmacol       Date:  1981-03       Impact factor: 2.953

Review 7.  Clinical pharmacokinetics of chlordiazepoxide.

Authors:  D J Greenblatt; R I Shader; S M MacLeod; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

8.  Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity.

Authors:  D J Greenblatt; M Divoll; D R Abernethy; L J Moschitto; R B Smith; R I Shader
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

9.  Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine.

Authors:  Christophe Abi Zeid Daou; Mohammad A Natout; Nadine El Hadi
Journal:  J Med Virol       Date:  2021-06-06       Impact factor: 20.693
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.